Abstract:Early recurrence after surgery could affect cancerous patients? prognosis, but the definition of early recurrence and its risk factors for esophageal squamous cell carcinoma (ESCC) patients are still unclear. This study analyzed the clinical data of 468 post-surgery recurrent ESCC patients retrospectively. A minimum p -value approach was used to evaluate the optimal cut-off value of recurrence free survival (RFS) to define early recurrence. Risk factors of early recurrence were developed based on a Cox model. The optimal cut-off value of RFS to distinguish early recurrence was 21 months ( p < 0.001). Independent risk factors for early recurrence included tumor locations (HR = 0.562, p < 0.001), pathological T stage (HR = 1.829, p < 0.001), tumor diameter (HR = 1.344, p = 0.039), positive lymph nodes (HR = 1.361, p < 0.001), and total resected lymph nodes (HR = 1.271, p = 044). For the late recurrent patients, there was a much more significant survival advantage for recurrence after concurrent chemoradiotherapy than that after sequential chemoradiotherapy and radiotherapy alone ( p = 0.0066). In conclusion, this study defined 21 months of RFS as early recurrence and also identified its risk factors. Concurrent chemoradiotherapy was suggested as preferred post-relapse treatment for late recurrent ESCC patients.

Definition and Risk Factors of Early Recurrence Based on Affecting Prognosis of Esophageal Squamous Cell Carcinoma Patients after Radical Resection.